13D Filings
Royalty Pharma plc
RPRX
Amendment
Ownership

4.80%

Total Shares

21,366,927

Issuer CIK

1802768

Event Date

Jun 11, 2026

Accepted

Jun 16, 2026, 04:30 PM

Reporting Persons (2)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
Butterfield Fiduciary Administrators Trust Company Limited
CO
4.80%21,366,92721,366,9270
Severgnini Achille G.
Individual
4.80%21,366,92721,366,9270
Disclosure Items (4)

Security Title

Class A Ordinary Shares, par value $0.0001 per share

Issuer Name

Royalty Pharma plc

Issuer Address

110 East 59th Street, New York, NY, 10022

Item 2 (a) is hereby amended and supplemented to include the amended and restated Annex A attached hereto and incorporated by reference herein. On May 26, 2026, R&H Trust Co. (Guernsey) Limited changed its name and registered address to Butterfield Fiduciary Administrators Trust Company Limited, P.O. Box 25, Martello Court, Admiral Park, St. Peter Port, GY1 3AP, Guernsey. Item 2(a) is hereby amended and supplemented to reflect this new name and address.

Percentage of Class

Items 5(a) - (c) and (e) of the Schedule 13D are hereby amended and restated in their entirety as follows: The aggregate number and percentage of Class A Shares beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition are reported as of June 12, 2026 and are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D and are incorporated herein by reference. As of June 12, 2026: (a) MGG Strategic directly holds 11,281,473 Class A Shares and (b) GG Strategic directly holds 10,085,454 Class A Shares. As of June 12, 2026, collectively, the Reporting Persons may be deemed to beneficially own an aggregate of 21,366,927 Class A Shares, representing beneficial ownership over 4.8% of the outstanding Class A Shares. The percentage of beneficial ownership in this Schedule 13D is based on an aggregate of 443,274,104 Class A Shares outstanding as of May 1, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 6, 2026. MGG Strategic is a sub-fund managed and administered by MGG SICAF. A board of directors consisting of M. Germano Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by MGG SICAF. Each member of the board disclaims beneficial ownership over such shares. MGG SICAF is owned by the MGG Trust of which M. Germano Giuliani is the beneficiary. The MGG Trust is the 100% economic owner of the shares held by MGG Strategic. GG Strategic is a sub-fund managed and administered by GG 1978 SICAF. A board of directors consisting of Giammaria Giuliani, Achille G. Severgnini, Marco Sterzi and Franco Toscano has voting and dispositive power over the securities managed by GG 1978 SICAF. Each member of the board disclaims beneficial ownership over such shares. GG 1978 SICAF is owned by the GG Trust, of which Giammaria Giuliani is the beneficiary (together with the MGG Trust, the "Trusts"). The GG Trust is the 100% economic owner of the shares held by GG Strategic. Each of M. Germano Giuliani and Giammaria Giuliani disclaim beneficial ownership over the shares beneficially owned by MGG Strategic and GG Strategic. The trustee of each of the Trusts is Butterfield Fiduciary Administrators Trust Company Limited. The protector of each of the Trusts is Achille G. Severgnini, who has the power to remove and replace the trustee of each the Trusts. Each of Butterfield Fiduciary Administrators Trust Company Limited and Mr. Severgnini disclaims beneficial ownership over the shares beneficially owned by the Trusts. Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that any Reporting Persons are the beneficial owner of the Class A Shares referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose and each of the Reporting Persons expressly disclaims beneficial ownership of such Class A Shares and any assertion or presumption that it or he and the other persons on whose behalf this statement is filed constitute a "group."

Number of Shares

See Item 5(a) above.

Transactions

Except as set forth in this Amendment No. 8 and in Annex B attached hereto as Exhibit 99.4, none of the Reporting Persons has effected any transaction in Class A Shares in the prior 60 days.

Date of 5% Ownership

As of June 12, 2026, the Reporting persons may no longer be deemed the beneficial owners of more than five percent of the Issuer's Class A Shares. The filing of this Amendment No. 8 represents the final amendment to the Schedule 13D and constitutes an exit filing for the Reporting Persons.

Item 7 of the Schedule 13D is hereby amended and supplemented as follows: 99.3 Annex A Directors of Butterfield Fiduciary Administrators Trust Company Limited* 99.4 Annex B Sales of Class A Shares* *filed herewith

Royalty Pharma plc — Schedule 13D | 13D Filings